跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
METHOTREXATE ADVZ methotrexate 25 mg/1 mL solution for injection pre-filled syringe
Approved
STANDARD
METHOTREXATE ADVZ methotrexate 25 mg/1 mL solution for injection pre-filled syringe
Boucher & Muir Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
e1eddda877343b93
Company
Boucher & Muir Pty Ltd
Type
Standard
Approval Details
Approval Id
e1eddda877343b93
Product Name
METHOTREXATE ADVZ methotrexate 25 mg/1 mL solution for injection pre-filled syringe
Artg Id
420297
Artg Name
METHOTREXATE ADVZ methotrexate 25 mg/1 mL solution for injection pre-filled syringe
Sponsor
Boucher & Muir Pty Ltd
Company Detail Path
/organization/boucher-and-muir-pty-ltd
Artg Date
2024-02-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
e1eddda877343b93
Type
Standard
Back to TGA Approvals
METHOTREXATE ADVZ methotrexate 25 mg/1 mL solution for injection pre-filled syringe - TGA Drug Approval Details
